175 related articles for article (PubMed ID: 36104654)
1. Assessing the Financial Value of Decentralized Clinical Trials.
DiMasi JA; Smith Z; Oakley-Girvan I; Mackinnon A; Costello M; Tenaerts P; Getz KA
Ther Innov Regul Sci; 2023 Mar; 57(2):209-219. PubMed ID: 36104654
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI's Patient Groups and Clinical Trials Project.
Levitan B; Getz K; Eisenstein EL; Goldberg M; Harker M; Hesterlee S; Patrick-Lake B; Roberts JN; DiMasi J
Ther Innov Regul Sci; 2018 Mar; 52(2):220-229. PubMed ID: 29714515
[TBL] [Abstract][Full Text] [Related]
3. The landscape of decentralized clinical trials (DCTs): focusing on the FDA and EMA guidance.
Park J; Huh KY; Chung WK; Yu KS
Transl Clin Pharmacol; 2024 Mar; 32(1):41-51. PubMed ID: 38586122
[TBL] [Abstract][Full Text] [Related]
4. Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics review.
van Rijssel TI; de Jong AJ; Santa-Ana-Tellez Y; Boeckhout M; Zuidgeest MGP; van Thiel GJMW;
Drug Discov Today; 2022 Oct; 27(10):103326. PubMed ID: 35870693
[TBL] [Abstract][Full Text] [Related]
5. Quantifying Site Burden to Optimize Protocol Performance.
Florez M; Smith Z; Olah Z; Martin M; Getz K
Ther Innov Regul Sci; 2024 Mar; 58(2):347-356. PubMed ID: 38191957
[TBL] [Abstract][Full Text] [Related]
6. Applying Systems Thinking to Inform Decentralized Clinical Trial Planning and Deployment.
Betcheva L; Kim JY; Erhun F; Oraiopoulos N; Getz K
Ther Innov Regul Sci; 2023 Sep; 57(5):1081-1098. PubMed ID: 37389795
[TBL] [Abstract][Full Text] [Related]
7. Decentralized clinical trials (DCTs): A few ethical considerations.
Petrini C; Mannelli C; Riva L; Gainotti S; Gussoni G
Front Public Health; 2022; 10():1081150. PubMed ID: 36590004
[TBL] [Abstract][Full Text] [Related]
8. The Ethics of Decentralized Clinical Trials and Informed Consent: Taking Technologies' Soft Impacts into Account.
van Rijssel TI; van Thiel GJMW; van Delden JJM;
Health Care Anal; 2024 May; ():. PubMed ID: 38764063
[TBL] [Abstract][Full Text] [Related]
9. Decentralized Clinical Trials in the Development of Drugs and Biological Products.
Robinson R; Sacks L
Ther Innov Regul Sci; 2024 Feb; ():. PubMed ID: 38305983
[TBL] [Abstract][Full Text] [Related]
10. Exploring the divergence in perspectives on clinical trial operations in South Korea during the COVID-19 pandemic: a comparison of a trial site and sponsors.
Kim YS; Kim A; Lee YS
Front Med (Lausanne); 2024; 11():1342184. PubMed ID: 38510454
[TBL] [Abstract][Full Text] [Related]
11. Implementation status and consideration for the globalisation of decentralised clinical trials: a cross-sectional analysis of clinical trial databases.
Sato T; Mizumoto S; Ota M; Shikano M
BMJ Open; 2023 Oct; 13(10):e074334. PubMed ID: 37821130
[TBL] [Abstract][Full Text] [Related]
12. Application of Internet of Medical/Health Things to Decentralized Clinical Trials: Development Status and Regulatory Considerations.
Sato T; Ishimaru H; Takata T; Sasaki H; Shikano M
Front Med (Lausanne); 2022; 9():903188. PubMed ID: 35733872
[TBL] [Abstract][Full Text] [Related]
13. Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective.
de Jong AJ; Shahid N; Zuidgeest MGP; Santa-Ana-Tellez Y; Hogervorst M; Goettsch W; Traore H; de Boer A; Gardarsdottir H;
Value Health; 2024 Mar; 27(3):294-300. PubMed ID: 38043711
[TBL] [Abstract][Full Text] [Related]
14. Economic return of clinical trials performed under the pediatric exclusivity program.
Li JS; Eisenstein EL; Grabowski HG; Reid ED; Mangum B; Schulman KA; Goldsmith JV; Murphy MD; Califf RM; Benjamin DK
JAMA; 2007 Feb; 297(5):480-8. PubMed ID: 17284698
[TBL] [Abstract][Full Text] [Related]
15. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
Adis International Ltd
Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
[TBL] [Abstract][Full Text] [Related]
16. Design and Execution of Sustainable Decentralized Clinical Trials.
Singh P; Burden AM; Natanegara F; Beckman RA
Clin Pharmacol Ther; 2023 Oct; 114(4):802-809. PubMed ID: 37489911
[TBL] [Abstract][Full Text] [Related]
17. Digital health technologies and Alzheimer's disease clinical trials: might decentralized clinical trials increase participation by people with cognitive impairment?
Leroy V; Gana W; Aïdoud A; N'kodo JA; Balageas AC; Blanc P; Bomia D; Debacq C; Fougère B
Alzheimers Res Ther; 2023 Apr; 15(1):87. PubMed ID: 37106429
[TBL] [Abstract][Full Text] [Related]
18. A secondary qualitative analysis of stakeholder views about participant recruitment, retention, and adherence in decentralised clinical trials (DCTs).
Coyle J; Rogers A; Copland R; De Paoli G; MacDonald TM; Mackenzie IS;
Trials; 2022 Jul; 23(1):614. PubMed ID: 35907888
[TBL] [Abstract][Full Text] [Related]
19. Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative.
Apostolaros M; Babaian D; Corneli A; Forrest A; Hamre G; Hewett J; Podolsky L; Popat V; Randall P
Ther Innov Regul Sci; 2020 Jul; 54(4):779-787. PubMed ID: 32557302
[TBL] [Abstract][Full Text] [Related]
20. The economic returns of pediatric clinical trials of antihypertensive drugs.
Baker-Smith CM; Benjamin DK; Grabowski HG; Reid ED; Mangum B; Goldsmith JV; Murphy MD; Edwards R; Eisenstein EL; Sun J; Califf RM; Li JS
Am Heart J; 2008 Oct; 156(4):682-8. PubMed ID: 18926149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]